METROPOLITAN LIFE INSURANCE CO/NY - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 122 filers reported holding REATA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.69 and the average weighting 0.6%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$159,160
+17.1%
1,561
+4.4%
0.01%
+14.3%
Q1 2023$135,925
+100.4%
1,495
-16.2%
0.01%
+133.3%
Q4 2022$67,812
+51.2%
1,7850.0%0.00%
+50.0%
Q3 2022$44,857
-17.3%
1,7850.0%0.00%0.0%
Q2 2022$54,246
-7.2%
1,7850.0%0.00%0.0%
Q1 2022$58,477
-70.6%
1,785
-76.3%
0.00%
-33.3%
Q4 2021$198,803
-73.8%
7,5390.0%0.00%
-72.7%
Q3 2021$758,499
-28.8%
7,539
+0.1%
0.01%
-26.7%
Q2 2021$1,065,862
+508.8%
7,531
+328.9%
0.02%
+400.0%
Q1 2021$175,073
-15.8%
1,756
+4.4%
0.00%0.0%
Q4 2020$207,929
+24.5%
1,682
-1.9%
0.00%0.0%
Q3 2020$167,075
-38.3%
1,715
-1.2%
0.00%
-40.0%
Q2 2020$270,851
-72.7%
1,736
-74.8%
0.01%
-76.2%
Q1 2020$993,059
-28.6%
6,880
+1.1%
0.02%
-8.7%
Q4 2019$1,391,759
+162.7%
6,808
+3.2%
0.02%
+155.6%
Q3 2019$529,834
-9.1%
6,599
+6.8%
0.01%
-10.0%
Q2 2019$583,083
+12.4%
6,180
+1.8%
0.01%
+11.1%
Q1 2019$518,888
+52.4%
6,0710.0%0.01%
+28.6%
Q4 2018$340,583
-31.4%
6,0710.0%0.01%
-22.2%
Q3 2018$496,365
-99.7%
6,071
+11.2%
0.01%
+200.0%
Q2 2018$190,936,000
+161.3%
5,460
+53.2%
0.00%
+200.0%
Q1 2018$73,077,000
+72253.5%
3,5630.0%0.00%0.0%
Q4 2017$101,000
-50.0%
3,563
-45.1%
0.00%0.0%
Q3 2017$202,000
-1.5%
6,4920.0%0.00%0.0%
Q2 2017$205,0006,4920.00%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
CPMG Inc 2,896,901$76,391,00014.09%
Opaleye Management Inc. 330,000$8,702,0001.85%
Highlander Partners, L.P. 27,600$728,0000.89%
Ikarian Capital, LLC 200,000$5,274,0000.79%
Integral Health Asset Management, LLC 103,000$2,716,0000.75%
KRS Capital Management, LLC 32,841$866,0000.74%
Ghost Tree Capital, LLC 55,000$1,450,0000.52%
MADDEN SECURITIES Corp 39,312$1,037,0000.49%
LBJ Family Wealth Advisors, Ltd. 30,359$801,0000.47%
Ikarian Capital, LLC 100,000$2,637,0000.39%
View complete list of REATA PHARMACEUTICALS INC shareholders